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So there I was, 35 years old and at the crossroads of my
scientiﬁc career. The current academic system in the
Netherlands, like in many other places around the world
(Powell, 2015), is not designed to have scientists staying in a
postdoc position forever. So, you are either deemed good
enough to become a permanent staff member, or you have
to leave academia at some point and try your luck in a
pharmaceutical company or elsewhere. I had not succeeded
in the former, but I also did not want to do the latter, so I took
a less threaded path and headed to China.
China seemed a good place to take my chances, as it is
one of the few countries where funding for R&D is growing
instead of shrinking (Van Noorden, 2014). I was lucky to get
in touch with Professor George F. Gao in Beijing, who
advised me to apply for a Fellowship for International Young
Scientists and come work in his Structural Virology lab. This
type of fellowship is one of the many funded by the Chinese
Academy of Sciences with the aim to enhance the inﬂux of
foreign scientists into its institutes (Fig. 1).
After having received the positive outcome of my applica-
tion and arranging the necessary paperwork to be able towork
inChina,mywife (whohad foundherself a job aswell) and I left
for Beijing in July 2012. Before arriving at the Institute of
Microbiology (IMCAS), I had been exchanging emails with
Christopher Vavricka, an American postdoc who was working
in the same lab since 2009 (Vavricka, 2011). Although the
information provided by him helped me to shape my expec-
tations, the culture shock was still considerable. Fortunately,
my Chinese colleagues were also very helpful and after a few
weeks, I could already conduct my ﬁrst experiments on one of
the internal proteins of an inﬂuenza-like virus discovered
recently in bats (Tefsen et al., 2014; Wu et al., 2014). During
my period at the IMCAS, I witnessed the hard work and ded-
ication of the students and staff in the lab. I also got a real taste
of Chinese culture, as many events in Chinese life are
accompanied by very delicious food.
In retrospect, I could not have come to a better laboratory,
as the ﬁrst cases of human-infecting H7N9 inﬂuenza strains
made their appearance in China in the spring of 2013. Not
only is inﬂuenza one of the main research topics in the lab of
Gao, but he also serves as the Deputy Director-General of
the Chinese Center for Disease Control and Prevention and
therefore has the responsibility to supervise the battles
against epidemics. During this hectic period, many of my
colleagues were working around the clock to solve the
structures of the inﬂuenza surface molecules hemagglutinin
and neuraminidase identiﬁed from the different clinical H7N9
isolates (Shi et al., 2013; Wu et al., 2013) and to track down
the origins of the virus (Liu et al., 2013).
Luckily, the H7N9 epidemic was relatively small and
quickly under control, helped by adequate sharing of infor-
mation and measures taken by the Chinese government,
which had learned from the SARS epidemic that affected the
country from 2002 to 2003. For me as a Dutchman working
in a Chinese lab, an interesting by-product of a letter in
Science about closing down live poultry markets to prevent
new infections by H7N9 (Gao, 2014), was that Gao was
mentioned in a Dutch national newspaper in a column by a
prominent emeritus professor (Borst, 2014).
In the meantime, other viral threats emerged around the
globe. The SARS-related corona virus MERS was causing
several fatalities in theMiddleEastand it posednewchallenges
for the eager scientists in the Gao lab to solve. One extraordi-
nary result was the elucidation of the complex structure of viral
surface spike protein together with its CD26 receptor by
Guangwen Lu and several other colleagues (Lu et al., 2013). In
March 2014, another, far more destructive epidemic started.
The Ebola virus struck Liberia, Sierra Leone and Guinea
with great force and claimed many lives (Alexander et al.,
2015). International aid was (and is) desperately needed in
these countries and China offered help by sending medical
teams to the stricken countries. The CDC-team going to
Sierra Leone in 2014 was led by Gao for two months (Gao
and Feng, 2014). One of my other colleagues, Jun Liu
(Fig. 2), ﬁrst went to Guinea and a few months later he went
to help in Sierra Leone as well (Tong et al., 2015).
Amidst all this global turmoil, I was about to leave Beijing
to become an Associate Professor at the Xi’an Jiaotong-
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Liverpool University (XJTLU) in Suzhou, an ancient city
close to Shanghai. This young university was founded in
2006 in a joint effort by Xi’an Jiaotong University, one of the
C9 League universities in China, and the University of
Liverpool and it aims to blend the best of both education
systems into its own and be a world class research-led
university. It offered me the chance to build up my own
research lab and it seemed like everything had fallen into
place for me (Fig. 3).
After one and a half year in Suzhou, I can only conﬁrm my
initial feelings. I enjoy teaching the eager students at my
university, although the language—the curriculum is taught
in English—poses sometimes difﬁculties to some of them
during assessments. XJTLU is one of the experiments by the
Chinese government to test education styles that differ from
the classic Chinese education system and one of the main
goals is to improve creative thinking amongst its student
population. It is wonderful to see how our students are
capable of detaching themselves quickly from twelve years
of merely exam-oriented learning.
Setting up my own laboratory has also been very stimu-
lating and I thoroughly enjoy the freedom of ﬁnally being able
to completely follow my own research interests. My research
focuses on the synthesis of the mycobacterial cell envelope
and will hopefully contribute to combating the growing
number of cases of patients that are infected with multi-drug
resistant Mycobacterium tuberculosis (WHO, 2014). Three
and a half years after going to China, I can only conclude
that it worked out great for me and I am excited to see what
the future will bring.
Figure 1. A joint meeting between China and Russia on inﬂuenza research held at the Institute of Microbiology, Chinese
Academy of Sciences in Beijing in 2014.
Figure 2. Jun Liu (third from right) and other members of
the CDC-teams that went to Africa to help combat the Ebola
outbreak in 2014.
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Figure 3. Posing in my lab at XJTLU together with two students, Xinzhu Fei (middle) and Jing Zhang (right).
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